Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYD.L Regulatory News (HYD)

  • There is currently no data for HYD

Form 8.5 (EPT/NON-RI)

27 May 2016 11:50

RNS Number : 5452Z
Arden Partners plc
27 May 2016
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Arden Partners plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Hydro International plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Hydro International plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26 May 2016

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

36,413

0.25%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

36,413

0.25%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p ordinary

Purchases

 

8,637

209p

207p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

27 May 2016

Contact name:

Norman Gould

Telephone number:

020 7614 5935

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOEAESXAEKKEFF
Date   Source Headline
5th Dec 20077:00 amRNSTotal Voting Rights
4th Dec 20074:30 pmRNSDirectorate Change
2nd Nov 200712:12 pmRNSAdditional Listing
31st Oct 20077:01 amRNSTotal Voting Rights
18th Oct 20075:14 pmRNSHolding(s) in Company
15th Oct 200712:31 pmRNSHolding(s) in Company
1st Oct 20072:33 pmRNSAdditional Listing
4th Sep 20077:01 amRNSInterim Results
16th Aug 20074:09 pmRNSNotice of Interim Results
16th Aug 20073:56 pmRNSAIM Rule 26
3rd Aug 20072:46 pmRNSHolding(s) in Company
2nd Jul 20071:05 pmRNSIFRS accounts for 2006
30th May 200712:01 pmRNSTotal Voting Rights
25th May 20079:58 amRNSAdditional Listing
24th May 20077:01 amRNSAGM Statement
16th May 200712:32 pmRNSHolding(s) in Company
16th May 200710:21 amRNSHolding(s) in Company
24th Apr 20074:49 pmRNSHolding(s) in Company
23rd Apr 20072:30 pmRNSAnnual Report and Accounts
18th Apr 200711:54 amRNSRe Contract
17th Apr 200710:48 amRNSRe Contract
30th Mar 20074:48 pmRNSTotal Voting Rights
30th Mar 20074:42 pmRNSMajor New Order Received
23rd Mar 20075:05 pmRNSAdditional Listing - AMNDT
23rd Mar 200711:13 amRNSAdditional Listing
19th Mar 20071:54 pmRNSHolding(s) in Company
19th Mar 20071:51 pmRNSHolding(s) in Company
16th Mar 20072:35 pmRNSHolding(s) in Company
5th Mar 20077:00 amRNSFinal Results
26th Feb 20077:00 amRNSNotice of Results
16th Feb 20074:51 pmRNSHolding(s) in Company
7th Dec 20062:40 pmRNSTotal Voting Rights
30th Aug 20067:00 amRNSInterim Results
10th Jul 20063:13 pmRNSDirectorate Change
23rd May 200610:57 amRNSDirector/PDMR Shareholding
19th May 200612:00 pmRNSAGM Statement
5th May 20067:00 amRNSDirectorate Change
2nd May 200610:58 amRNSAdditional Listing
3rd Apr 200612:36 pmRNSHolding(s) in Company
20th Mar 200612:08 pmRNSDirector/PDMR Shareholding
7th Mar 20067:01 amRNSFinal Results
28th Feb 20063:21 pmRNSNotice of Results
7th Feb 20064:06 pmRNSHolding(s) in Company
26th Jan 200612:23 pmRNSHolding(s) in Company
1st Dec 200510:13 amRNSRe Contract Wins
30th Nov 20053:06 pmRNSHolding(s) in Company
23rd Nov 20054:01 pmRNSAdditional Listing-Correction
21st Nov 20053:16 pmRNSAdditional Listing
8th Nov 20053:21 pmRNSHolding(s) in Company
23rd Sep 200511:17 amRNSContract Wins&DirectorOptions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.